Endothelin 1 and cyclic guanosine monophosphate in nonimmunological progression of mesangial proliferative glomerulonephritis

Contrib Nephrol. 1995:111:129-33; discussion 134. doi: 10.1159/000423887.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Cyclic GMP / biosynthesis*
  • Cyclic GMP / urine
  • Disease Progression
  • Endothelins / metabolism*
  • Endothelins / urine
  • Glomerulonephritis, IGA / complications
  • Glomerulonephritis, IGA / drug therapy
  • Glomerulonephritis, IGA / physiopathology*
  • Glomerulonephritis, IGA / urine
  • Glomerulonephritis, Membranoproliferative / complications
  • Glomerulonephritis, Membranoproliferative / drug therapy
  • Glomerulonephritis, Membranoproliferative / physiopathology*
  • Glomerulonephritis, Membranoproliferative / urine
  • Humans
  • Hypertension, Renal / drug therapy
  • Hypertension, Renal / etiology
  • Hypertension, Renal / urine
  • Isosorbide Dinitrate / analogs & derivatives
  • Isosorbide Dinitrate / pharmacology
  • Isosorbide Dinitrate / therapeutic use
  • Nitric Oxide / metabolism
  • Pilot Projects
  • Vasodilator Agents / pharmacology
  • Vasodilator Agents / therapeutic use

Substances

  • Endothelins
  • Vasodilator Agents
  • Nitric Oxide
  • Cyclic GMP
  • Isosorbide Dinitrate
  • isosorbide-5-mononitrate